{
    "paper_id": "3618eef2701857e1a28d20cb79f1a9b47470ad4f",
    "metadata": {
        "title": "Characteristic and quantifiable COVID-19-like abnormalities in CT-and PET/CT- 1 imaged lungs of SARS-CoV-2-infected crab-eating macaques (Macaca fascicularis) 2 3 SARS-CoV-2 pulmonary abnormalities in macaques",
        "authors": [
            {
                "first": "Courtney",
                "middle": [
                    "L"
                ],
                "last": "Finch",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Ian",
                "middle": [],
                "last": "Crozier",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Laboratory for Cancer Research supported by",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick"
                    }
                },
                "email": ""
            },
            {
                "first": "Ji",
                "middle": [
                    "Hyun"
                ],
                "last": "Lee",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Russ",
                "middle": [],
                "last": "Byrum",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Timothy",
                "middle": [
                    "K"
                ],
                "last": "Cooper",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Janie",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Liang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Kaleb",
                "middle": [],
                "last": "Sharer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Jeffrey",
                "middle": [],
                "last": "Solomon",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Laboratory for Cancer Research supported by",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick"
                    }
                },
                "email": ""
            },
            {
                "first": "Philip",
                "middle": [
                    "J"
                ],
                "last": "Sayre",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Gregory",
                "middle": [],
                "last": "Kocher",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Christopher 5 Bartos",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Nina",
                "middle": [
                    "M"
                ],
                "last": "Aiosa",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Marcelo",
                "middle": [],
                "last": "Castro",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Peter",
                "middle": [
                    "A"
                ],
                "last": "Larson",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "United States Army Medical Research Institute of Infectious Diseases",
                    "location": {
                        "addrLine": "Fort Detrick",
                        "postCode": "20, 21702",
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Ricky",
                "middle": [],
                "last": "Adams",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Brett",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Wisconsin-Madison",
                    "location": {
                        "postCode": "24, 53706",
                        "settlement": "Madison",
                        "region": "WI",
                        "country": "USA 25"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Beitzel",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "United States Army Medical Research Institute of Infectious Diseases",
                    "location": {
                        "addrLine": "Fort Detrick",
                        "postCode": "20, 21702",
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Nicholas",
                "middle": [],
                "last": "Di Paola",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "United States Army Medical Research Institute of Infectious Diseases",
                    "location": {
                        "addrLine": "Fort Detrick",
                        "postCode": "20, 21702",
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Jeffrey",
                "middle": [
                    "R"
                ],
                "last": "Kugelman",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "United States Army Medical Research Institute of Infectious Diseases",
                    "location": {
                        "addrLine": "Fort Detrick",
                        "postCode": "20, 21702",
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Jonathan",
                "middle": [
                    "R"
                ],
                "last": "Kurtz",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Tracey 7 Burdette",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Martha",
                "middle": [
                    "C"
                ],
                "last": "Nason",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious Diseases",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Irwin",
                "middle": [
                    "M"
                ],
                "last": "Feuerstein",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Gustavo",
                "middle": [],
                "last": "Palacios",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "United States Army Medical Research Institute of Infectious Diseases",
                    "location": {
                        "addrLine": "Fort Detrick",
                        "postCode": "20, 21702",
                        "settlement": "Frederick",
                        "region": "Maryland",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Marisa",
                "middle": [
                    "C"
                ],
                "last": "St",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Claire",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Matthew",
                "middle": [
                    "G"
                ],
                "last": "Lackemeyer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Reed",
                "middle": [
                    "F"
                ],
                "last": "Johnson",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Katarina",
                "middle": [
                    "M"
                ],
                "last": "Braun",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Wisconsin-Madison",
                    "location": {
                        "postCode": "24, 53706",
                        "settlement": "Madison",
                        "region": "WI",
                        "country": "USA 25"
                    }
                },
                "email": ""
            },
            {
                "first": "Mitchell",
                "middle": [
                    "D"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ramuta",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jiro",
                "middle": [],
                "last": "Wada",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Connie",
                "middle": [
                    "S"
                ],
                "last": "Schmaljohn",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": ""
            },
            {
                "first": "Thomas",
                "middle": [
                    "C"
                ],
                "last": "Friedrich",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Wisconsin-Madison",
                    "location": {
                        "postCode": "24, 53706",
                        "settlement": "Madison",
                        "region": "WI",
                        "country": "USA 25"
                    }
                },
                "email": "tfriedri@wisc.edu"
            },
            {
                "first": "David",
                "middle": [
                    "H"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "O",
                "middle": [
                    "&apos;"
                ],
                "last": "Connor",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Wisconsin-Madison",
                    "location": {
                        "addrLine": "26 Madison",
                        "postCode": "53706",
                        "region": "WI",
                        "country": "USA 27"
                    }
                },
                "email": ""
            },
            {
                "first": "Jens",
                "middle": [
                    "H"
                ],
                "last": "Kuhn",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "National Institute of Allergy and Infectious",
                    "location": {
                        "addrLine": "13 Diseases"
                    }
                },
                "email": "42kuhnjens@mail.nih.gov"
            },
            {
                "first": "",
                "middle": [],
                "last": "Finch",
                "suffix": "",
                "affiliation": {
                    "laboratory": "National Laboratory for Cancer Research supported by",
                    "institution": "",
                    "location": {
                        "settlement": "Frederick"
                    }
                },
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "H"
                ],
                "last": "O&apos;connor",
                "suffix": "",
                "affiliation": {},
                "email": "dhoconno@wisc.edu"
            }
        ]
    },
    "abstract": [
        {
            "text": "43 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 3 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing an 44 exponentially increasing number of coronavirus disease 19 (COVID-19) cases 45 globally. Prioritization of medical countermeasures for evaluation in randomized 46 clinical trials is critically hindered by the lack of COVID-19 animal models that 47 enable accurate, quantifiable, and reproducible measurement of COVID-19 48 pulmonary disease free from observer bias. We first used serial computed 49 tomography (CT) to demonstrate that bilateral intrabronchial instillation of SARS-50 CoV-2 into crab-eating macaques (Macaca fascicularis) results in mild-to-moderate 51 lung abnormalities qualitatively characteristic of subclinical or mild-to-moderate 52 COVID-19 (e.g., ground-glass opacities with or without reticulation, paving, or 53 alveolar consolidation, peri-bronchial thickening, linear opacities) at typical 54 locations (peripheral>central, posterior and dependent, bilateral, multi-lobar). We 55 then used positron emission tomography (PET) analysis to demonstrate increased 56 FDG uptake in the CT-defined lung abnormalities and regional lymph nodes. 57 PET/CT imaging findings appeared in all macaques as early as 2 days post-58 exposure, variably progressed, and subsequently resolved by 6-12 days post-59 exposure. Finally, we applied operator-independent, semi-automatic quantification 60 of the volume and radiodensity of CT abnormalities as a possible primary endpoint 61 for immediate and objective efficacy testing of candidate medical countermeasures. 62 63",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Finch et al. 5 29). However, in both human disease and animal models, the temporal and mechanistic 90 relationship between viral replication, subsequent immunopathology (30, 31) , and clinical 91 disease remains uncertain. Furthermore, in the available NHP models, all of which are 92 sublethal, markers of clinical disease (cage-side scoring, chest X-ray) have been of 93 limited sensitivity. More concerningly, both metrics are subject to observer bias (32-35). 94",
            "cite_spans": [
                {
                    "start": 169,
                    "end": 173,
                    "text": "(30,",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 174,
                    "end": 177,
                    "text": "31)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Reliable animal models needed for rapid development and evaluation of candidate 95 medical countermeasures (MCMs) require an unbiased reproducible and quantifiable 96 metric of disease that mirrors key aspects of COVID-19. Based on the rather limited X-97 ray findings in the lungs of reported NHP models of SARS-CoV-2 infection with either 98 mild or no clinical signs (11, 25, 27-29), we turned to high-resolution chest CT and 99",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "PET/CT to characterize lung abnormalities in infected NHPs toward longitudinal 100 quantitative comparison. 101",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "We used direct bilateral primary intrabronchial instillation in a 1-day-apart 102 staggered design to expose two groups of three crab-eating macaques (Macaca 103 fascicularis) to medium (mock group macaques M1-3) or medium including 3.65x10 6 104 pfu/macaque of SARS-CoV-2 (virus group macaques V1-3) (Supplementary Table 1) . 105",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 316,
                    "end": 324,
                    "text": "Table 1)",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "All macaques were observed daily for 11 days prior to exposure (day [D] 0) and for 30 106 days post-exposure. Physical examination scores and blood, conjunctival, 107 nasopharyngeal, oropharyngeal, rectal, fecal, and urine specimens were collected at 108 identical timepoints. Virus-exposed macaques were indistinguishable from mock group 109 macaques during the pre-exposure time period. Two pre-exposure chest CT and whole-110 previously published results (11, (25) (26) (27) (28) (29) , none of the macaques developed any major 113 clinical abnormalities (including by cage-side assessment and clinical scoring or physical 114 examination) throughout the study and clinical laboratory results were not significantly 115 different between the mock-exposed and virus-exposed groups (Supplementary Tables  116   2-3) . SARS-CoV-2 RNA could not be detected by RT-qPCR in any sample from mock-117 exposed macaques but was variably present during the early days post-exposure in 118 conjunctival, fecal, nasopharyngeal, oral, and rectal swabs, but never in plasma or urine 119 (Figure 2a) . Anti-SARS-CoV-2 IgG antibodies were not detectable by ELISA in mock-120 exposed macaques but were detectable at D10 post-exposure and continued to rise in all 121 virus-exposed macaques to at least D19 (Figure 2b) . Consistent with ELISA results, 122 fluorescent neutralization titers generated from sera were undetected until D10 and were 123 detected only in virus-exposed macaques (Figure 2c) . Longitudinal measurement of 124 selected peripheral cytokines revealed between-and within-group differences with 125 marked abnormalities noted in macaque V3, which also had the highest IgG antibody 126 titers (Supplementary Figure 1) . 127",
            "cite_spans": [
                {
                    "start": 68,
                    "end": 71,
                    "text": "[D]",
                    "ref_id": null
                },
                {
                    "start": 458,
                    "end": 462,
                    "text": "(11,",
                    "ref_id": null
                },
                {
                    "start": 463,
                    "end": 467,
                    "text": "(25)",
                    "ref_id": null
                },
                {
                    "start": 468,
                    "end": 472,
                    "text": "(26)",
                    "ref_id": null
                },
                {
                    "start": 473,
                    "end": 477,
                    "text": "(27)",
                    "ref_id": null
                },
                {
                    "start": 478,
                    "end": 482,
                    "text": "(28)",
                    "ref_id": null
                },
                {
                    "start": 483,
                    "end": 487,
                    "text": "(29)",
                    "ref_id": null
                }
            ],
            "ref_spans": [
                {
                    "start": 783,
                    "end": 816,
                    "text": "(Supplementary Tables  116   2-3)",
                    "ref_id": "FIGREF9"
                },
                {
                    "start": 1074,
                    "end": 1085,
                    "text": "(Figure 2a)",
                    "ref_id": null
                },
                {
                    "start": 1290,
                    "end": 1301,
                    "text": "(Figure 2b)",
                    "ref_id": null
                },
                {
                    "start": 1472,
                    "end": 1483,
                    "text": "(Figure 2c)",
                    "ref_id": null
                },
                {
                    "start": 1711,
                    "end": 1720,
                    "text": "Figure 1)",
                    "ref_id": "FIGREF9"
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "With the exception of minor and transient abnormalities on baseline imaging, CT 128 scans of all mock-exposed macaques appeared generally normal over the entire study 129 period (Supplementary Figure 2) . However, all virus group macaques developed lung 130 abnormalities clearly visible by chest CT as early as D2. Qualitatively, the distribution 131 morphology, and duration of abnormalities described a spectrum similar to mild-132 moderately ill humans with COVID-19. Characteristic CT findings in all virus group 133 macaques included bilateral peripheral GGOs variably in association with intra-or 134 interlobular septal prominence (so-called \"crazy paving\"), reticular or reticulonodular 135 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 7 opacities, peri-bronchial thickening, subpleural nodules, and, in one macaque, dense 136 alveolar consolidation with air bronchograms (Figures 3-4a, Videos 1-3 Increased FDG uptake detected by PET (Figure 6, Supplementary Figures 4-5 ) 146 corresponded well to the structural changes in the lungs observed by CT, and regional 147 lymph node uptake was seen in all virus group macaques at D2. In macaque V1, FDG 148 uptake decreased in the lungs at D6 but increased in mediastinal lymph nodes, and new 149 FDG uptake was identified in the spleen. The two macaques (V2, V3) with persistent or 150 progressive structural abnormalities on chest CT had variable changes in FDG uptake 151 associated with the structural abnormalities in the lungs (some markedly increased, some 152 improved) with an accompanying marked increase in FDG uptake in regional lymph 153 nodes and spleens on D6. PET scan on D12 revealed normalization of previous areas of 154 increased FDG uptake in the lung parenchyma in all three virus-exposed macaques, and 155 persistent increased FDG update in regional lymph nodes and spleen. Mock-exposed 156 macaques did not have similar increased FDG uptake with the exception of transient 157 increased uptake in regional lymph nodes after mock-exposure in a single macaque (M1). 158 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 8",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 178,
                    "end": 202,
                    "text": "(Supplementary Figure 2)",
                    "ref_id": null
                },
                {
                    "start": 896,
                    "end": 921,
                    "text": "(Figures 3-4a, Videos 1-3",
                    "ref_id": "FIGREF9"
                },
                {
                    "start": 959,
                    "end": 995,
                    "text": "(Figure 6, Supplementary Figures 4-5",
                    "ref_id": null
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Quantification of the SUVmax in selected regions of interest (ROI) in the lung, specific 159 regional lymph nodes, and spleen mapped well to the qualitative findings in both mock-160 exposed and virus-exposed macaques (Figure 7) . 161 CT images can be used for quantification of lung abnormalities using measures of 162 volume or radiodensity, i.e., total lung volume (LV); average radiodensity in the total 163 lung volume (LD); hyperdense volume (HV), a volume of lung in which radiodensity 164 (Hounsfield units, HU) is above a pre-defined threshold; and average radiodensity in the 165 hyperdense volume (hyperdensity, HD). Normalized changes from a pre-exposure 166 baseline can be longitudinally measured as the percent change in the volume of lung 167 hyperdensity (PCLH). Toward standardization across lung volumes, PCLH can be also be 168 expressed as a percent of total lung volume (PCLH/LV). Increases in PCLH or PCLH/LV 169 were not seen in the mock-exposed macaques over the entire study (Figure 8a A key advantage of quantifiable CT chest imaging readout over serial euthanasia 212 studies, in addition to potentially reduced experimental animal numbers, is the ability not 213 only to evaluate between-group differences, but also to compare severity and duration of 214 disease at higher resolution in single animals and even in isolated parenchymal areas 215 sequentially. This approach can reduce the error inherent in cross-sectional sampling of 216 individual animals at single timepoints. Imaging does, however, introduce its own 217 experimental complexities and limitations. As we aimed to evaluate whether PCLH (or 218 other CT imaging readouts presented in Figure 8 ) could be a useful quantitative readout 219 for radiographic progression in the SARS-CoV-2 infected lung, we chose not to include 220 irradiated inactivated SARS-CoV-2 in the mock inoculum to avoid antigen-induced 221 inflammation and related radiographic changes. For similar reasons, and to avoid 222 artificial dissemination of SARS-CoV-2, we specifically did not perform bronchoalveolar 223 lavage (BAL) to obtain lung samples for downstream cellular, molecular, and virologic 224 analysis (45, 46) and did not perform lung biopsies. The frequency of anesthesia and 225 instrument availability pragmatically limit imaging to carefully chosen timepoints during 226 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 11 a study. In particular, the extended time required to perform PET imaging resulted in 227 logistical limitations of the number of macaques that could be included in the study. 228",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 218,
                    "end": 228,
                    "text": "(Figure 7)",
                    "ref_id": null
                },
                {
                    "start": 1001,
                    "end": 1011,
                    "text": "(Figure 8a",
                    "ref_id": null
                },
                {
                    "start": 1681,
                    "end": 1689,
                    "text": "Figure 8",
                    "ref_id": null
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Finally, with complete resolution of radiographic abnormalities by the end of the study 229 period, we opted not to euthanize these macaques to be able to perform a re-exposure 230 study in the future. Thus, we cannot correlate radiographic with histopathologic findings. 231",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Future studies should extend our initial findings in several directions. First, 232",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "follow-up confirmation of these pilot results in this model of mild-moderate COVID-19 233 is needed to further establish quantifiable lung CT as a reliable disease readout and to 234 forge imaging-pathologic correlates in macaques euthanized at peak radiographic 235 abnormality. Confirmation should enable proof-of-concept evaluation of whether a 236 candidate MCM will indeed significantly decrease peak or AUC of PCLH or PCLH/LV 237 compared to untreated infected control macaques. Data from additional macaques will be 238 used to confirm the sensitivity and relevance of the AUC0-8 and AUC0-30 for PCLH or 239 PCLH/LV as robust measures of lung changes from CT evaluation. 240",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "In parallel, disease severity could possibly be increased in the crab-eating 241 macaque model by optimizing delivery of SARS-CoV-2 to the most vulnerable lung (via 242 aerosol or more distal bronchoscopic delivery), with the ultimate goal of using the CT-243 quantifiable volume or radiodensity readouts to model the sick hospitalized human. 244",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Other groups are already evaluating NHPs of diverse species as possible COVID-245 19 models. In these models, serial chest CT imaging after intrabronchial instillation of 246 SARS-CoV-2 could be used to establish a meaningful and quantifiable COVID-19-like 247 disease readout that will enable objective evaluation of medical countermeasures and also 248 a comparison of SARS-CoV-2-induced lung abnormalities in different NHP models. The macaques were split into 2 groups of 3 animals each (Supplementary Table 1) . 315",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 505,
                    "end": 513,
                    "text": "Table 1)",
                    "ref_id": "TABREF1"
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Mock group (M) macaques received 2 ml of DMEM + 2% heat-inactivated FBS into each 316 bronchus by direct bilateral primary post-carinal intrabronchial instillation, followed by a 317 1-ml normal saline flush and then 5 ml air. Virus group (V) macaques were exposed the SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 15 same way with each 2-ml instillate containing 9.13x10 5 pfu/ml (i.e., a total exposure dose 319 of 3.65x10 6 pfu) of SARS-CoV-2 followed by 1-ml saline flush and then 5 ml air. All 320 macaques were sedated prior to instillation. Prior to administering anesthesia, 321 glycopyrrolate (0.06 mg/kg) was delivered intramuscularly to reduce saliva secretions. 322",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Next, each macaque received 10 mg/kg ketamine and then 35 \u03bcg/kg dexmedetomidine 323 intramuscularly. To reverse anesthesia, 0.15 mg/kg atipamezole was administered 324",
            "cite_spans": [],
            "ref_spans": [],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "intravenously. All macaques were evaluated daily for health and were periodically 325 Table 4 ). Cage-side and physical exam scoring 336 criteria were developed in collaboration with National Primate Research Centers 337 (NPRCs) to standardize disease assessment and compare disease outcomes between NHP 338 models. Heart rate was not incorporated into the physical exam scores until D2 because 339 heart rate score was determined as beats per minute over baseline. Baseline heart rate was 340 determined as an average over three timepoints, D-11, D-5/D-6, and D0 (except for 341 ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 86,
                    "end": 93,
                    "text": "Table 4",
                    "ref_id": null
                }
            ],
            "section": "SARS-CoV-2 pulmonary abnormalities in macaques"
        },
        {
            "text": "Normalized with baseline Density/radiodensity difference with baseline",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Individual macaques Average"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "A new coronavirus associated with human respiratory disease in",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "A pneumonia outbreak associated with a new coronavirus of 769 probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "",
            "pages": "270--273",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "A novel coronavirus from patients with pneumonia in China",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "World Health Organization, Coronavirus (COVID-19",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Clinical course and outcomes of critically ill patients with SARS-775",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, 776 observational study",
            "authors": [],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "8",
            "issn": "",
            "pages": "475--481",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Clinical characteristics of coronavirus disease 2019 in China",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Clinical findings in a group of patients infected with the 2019 780 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case 781 series",
            "authors": [
                {
                    "first": "X.-W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "BMJ",
            "volume": "368",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Covid-19 in critically ill patients in the Seattle region -case 783 series",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "K"
                    ],
                    "last": "Bhatraju",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Clinical features of patients infected with 2019 novel coronavirus 785 in Wuhan",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "China. Lancet",
            "volume": "395",
            "issn": "",
            "pages": "497--506",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 36",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "The incubation period of coronavirus disease 2019 (COVID-787 19) from publicly reported confirmed cases: estimation and application",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Lauer",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Intern Med",
            "volume": "788",
            "issn": "",
            "pages": "577--582",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Age-related rhesus macaque models of COVID-19",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Animal Model",
            "volume": "790",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "COVID-19): A Critical 792 Review of the Literature to Date",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Raptis",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Chest CT and Coronavirus Disease",
            "volume": "",
            "issn": "",
            "pages": "1--4",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Epidemiological and clinical characteristics of 26 asymptomatic 794 SARS-CoV-2 carriers",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Incidental findings suggestive of Covid-19 in asymptomatic 796 patients undergoing nuclear medicine procedures in a high prevalence region",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Albano",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Histopathologic changes and SARS-CoV-2 immunostaining in 799 the lung of a patient with COVID-19",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Intern Med",
            "volume": "172",
            "issn": "",
            "pages": "629--632",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Pathological findings of COVID-19 associated with acute respiratory 801 distress syndrome",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "8",
            "issn": "",
            "pages": "420--422",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Multiscale 3-dimensional pathology findings of COVID-19 diseased 803 lung using high-resolution cleared tissue microscopy. bioRxiv",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Pulmonary and cardiac pathology in Covid-19: the first autopsy 806 series from New Orleans. medRxiv",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Fox",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Autopsy findings and venous thromboembolism in patients 808 with COVID-19: a prospective cohort study",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wichmann",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ann Intern Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 37",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bao",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Susceptibility of ferrets, cats, dogs, and other domesticated animals to",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Infection and rapid transmission of SARS-CoV-2 in ferrets",
            "authors": [
                {
                    "first": ". Y.-I",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell 814 Host Microbe",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Simulation of the clinical and pathological manifestations of 816 coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: 817 implications for disease pathogenesis and transmissibility",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "-W",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Susceptibility of tree shrew to SARS-CoV-2 infection. bioRxiv",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "819",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Ocular conjunctival inoculation of SARS-CoV-2 can cause mild",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "COVID-19 in Rhesus macaques. bioRxiv",
            "authors": [],
            "year": 2003,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Comparative pathogenesis of COVID-19, MERS, and SARS in a 823 nonhuman primate model",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Rockx",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Infection with novel coronavirus (SARS-CoV-2) causes 825 pneumonia in the rhesus macaques",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Shan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Comparison of SARS-CoV-2 infections among 3 species of non-828 human primates. bioRxiv",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Respiratory disease in rhesus macaques inoculated with 830 SARS-CoV-2",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "J"
                    ],
                    "last": "Munster",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Dysregulation of immune response in patients with COVID-19 in",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "COVID-19: immunopathology and its implications for therapy",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Nat Rev",
            "volume": "834",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Frequency and distribution of chest radiographic findings in",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "Y F"
                    ],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "COVID-19 positive patients",
            "authors": [],
            "year": 2019,
            "venue": "Radiology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Interobserver reliability of the chest radiograph in 838 community-acquired pneumonia",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "N"
                    ],
                    "last": "Albaum",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "PORT Investigators. Chest",
            "volume": "110",
            "issn": "",
            "pages": "343--350",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Portable chest X-ray in coronavirus 841 disease-19 (COVID-19): a pictorial review",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jacobi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bernheim",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Eber",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Imaging",
            "volume": "64",
            "issn": "",
            "pages": "35--42",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Chest x-ray findings in 636 ambulatory patients with",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Weinstock",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "COVID-19 presenting to an urgent care center: a normal chest x-ray is no 844 guarantee",
            "authors": [],
            "year": 2020,
            "venue": "J Urgent Care Med",
            "volume": "14",
            "issn": "",
            "pages": "13--18",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Bias in radiology: the how and 846 why of misses and misinterpretations",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "P"
                    ],
                    "last": "Busby",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Courtier",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Glastonbury",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Radiographics",
            "volume": "38",
            "issn": "",
            "pages": "236--247",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Error and discrepancy in radiology: inevitable or avoidable? Insights 848 Imaging",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "P"
                    ],
                    "last": "Brady",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "8",
            "issn": "",
            "pages": "171--182",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Observer bias 850 in lung nodule detection with spiral CT",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "E"
                    ],
                    "last": "Seltzer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "F"
                    ],
                    "last": "Judy",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jacobson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Swensson",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Feldman",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Academic Radiology",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Interpretive error in radiology",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Waite",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "AJR Am J Roentgenol",
            "volume": "208",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 39",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Cytokine release syndrome in severe COVID-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "June",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "854",
            "issn": "",
            "pages": "473--474",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "On the alert for cytokine storm: immunopathology in 856 COVID-19",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Henderson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Arthritis Rheumatol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Clinical and immunological features of severe and moderate 858 coronavirus disease 2019",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Invest",
            "volume": "130",
            "issn": "",
            "pages": "2620--2629",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Clinical predictors of mortality 860 due to COVID-19 based on an analysis of data of 150 patients from Wuhan",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ruan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Risk factors for severity and mortality in adult COVID-19 inpatients 863 in Wuhan",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Allergy Clin Immunol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Bronchoalveolar lavage affects computed tomographic and 868 radiographic characteristics of the lungs in healthy dogs",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Vet Radiol Ultrasound",
            "volume": "869",
            "issn": "59",
            "pages": "564--570",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Inactivation and safety testing of Middle East Respiratory 871",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Syndrome Coronavirus",
            "authors": [],
            "year": 2015,
            "venue": "J Virol Methods",
            "volume": "223",
            "issn": "",
            "pages": "13--18",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Panmicrobial oligonucleotide array for diagnosis of infectious 873 diseases",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Palacios",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Emerg Infect Dis",
            "volume": "13",
            "issn": "",
            "pages": "73--81",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Influenza A and methicillin-resistant Staphylococcus aureus 877 co-infection in rhesus macaques -A model of severe pneumonia",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Chertow",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Antiviral Res",
            "volume": "878",
            "issn": "",
            "pages": "120--129",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "The nonhuman primate in nonclinical drug development and 880 safety assessment",
            "authors": [
                {
                    "first": "I",
                    "middle": [
                        "D"
                    ],
                    "last": "Bolton",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "",
            "volume": "882",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Time course of lung changes on chest CT during recovery from 2019 883 novel coronavirus (COVID-19) pneumonia",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Radiology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Mass preserving image registration for lung CT",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Gorbunova",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Med Image 888 Anal",
            "volume": "16",
            "issn": "",
            "pages": "786--795",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "3D Slicer as an image computing platform for the Quantitative 890",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fedorov",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Imaging Network",
            "authors": [],
            "year": 2012,
            "venue": "Magn Reson Imaging",
            "volume": "30",
            "issn": "",
            "pages": "1323--1341",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "A rhesus macaque model of Asian-lineage Zika virus 892 infection",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dudley",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Commun",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "body 2-deoxy-2-[ 18 F]-fluoro-D-glucose (FDG) PET/CTs and eight post-exposure CTs and 111 three post-exposure PETs were performed at identical timepoints (Figure 1). In line with 112 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 6",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 3). Longitudinal serial CT scans showed heterogeneity in the 138 duration and evolution of these abnormalities over the next week from rapid 139 improvement within a few days (macaque V1) to persistence and progression (macaques 140 V2, V3)(Figure 4a, Supplementary Figure 3). Nonetheless, by D19, chest CT 141 universally showed complete or nearly complete resolution of lung abnormalities in all 142 virus group macaques. Individual and per-group average radiologist-derived CT scores 143 (adapted from a scoring system generated from human COVID-19 CT images) 144 demonstrate the extent and duration of these qualitative findings (Figure 5). 145",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 2). However, post-exposure increases in PCLH or PCLH/LV 171 were noted in all virus group macaques starting at D2, notably with heterogeneity in both 172 the peak and duration of PCLH and PCLH/LV that corresponded well to longitudinal 173 qualitative chest CT observations in individual virus group macaques (Figure 4b, Figure 174",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "8a-d, Supplementary Figure 2). Though both measures captured similar differences 175 between groups, the within-group variability was unsurprisingly less with PCLH/LV 176 versus PCLH. The virus group had significantly higher cumulative PCLH/LV over days 177 0-30 as summarized by the area under the curve (AUC0-30; p=0.01). The AUC0-8 for days 178 0-8 showed a similar trend (p=0.06), as did the AUC0-8 and AUC0-30 for the PCLH 179 (p=0.06 and p=0.03, et al. 9 A comparison of PCLH or PCLH/LV (Figure 8a-d) and absolute radiodensity 181 (change in HD, change in LD) (Figure 8e-h) highlights similarities and differences 182 windowed by these readouts that are particularly apparent as the CT abnormalities 183 evolved in macaque V3. In this macaque, dense consolidation in the left lung reached 184 peak radiodensity at D6, subsequently evolving toward a larger volume of less dense 185 mixed consolidation and GGO at D8 (Figure 4a). This progression of findings is 186 captured as an increase in PCLH (Figure 8a) and PCLH/LV (Figure 8c) from D6-8, but 187 a sharp decline in HD (Figure 8e) over the same period. 188 Quantifiable changes in CT lung abnormalities, e.g., AUC of the PCLH/LV curve 189 in an appropriately powered macaque study, could be used to objectively evaluate 190 efficacy of candidate MCMs, including vaccines and therapeutics. Although the 191 described crab-eating macaque model windows only mild to moderate radiographic 192 disease, it captures heterogeneity in both severity and duration of disease; the readout can 193 be similarly applied to any larger animal model of increased severity should they become 194 available in the future. These objective measurements add to semi-quantitative scoring, 195 which is potentially subject to observer bias in experimental settings (36-39); in our 196 study, semi-quantitative findings include radiologist-derived CT lung scores (Figure 5) 197 or mean SUVmax measured in operator-selected regions of interest (ROIs) on PET/CT 198 scans (Figure 7). 199 Of interest, the disease heterogeneity captured by our imaging readouts is 200 mirrored to some degree in thus-far limited measures of innate or adaptive immunity, 201 namely in ELISA and neutralizing antibody titers and in longitudinal measurements of 202 peripheral cytokines. Conclusions cannot be meaningfully drawn from the small numbers 203 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 10 of measurements taken from only three macaques; nonetheless, between-and within-204 group differences in cytokines that have been identified as biomarkers of disease, disease 205 severity, and disease outcome in humans (30, 40-44) are observed. Most notable in this 206 regard is a remarkable concentration increase of cytokines associated with cytokine 207 release syndrome (aka \"cytokine storm\"), such as C-X-C motif chemokine ligand 8 208 (CXCL8), interleukin (IL) 6, IL13, IL15, IL1 receptor antagonist (IL1RN), and tumor 209 necrosis factor (TNF), starting around D6 in the macaque (V3) with the most significant 210 CT and PET/CT abnormalities. 211",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "respiratory syndrome coronavirus 2 (SARS-CoV-2; Nidovirales: 253 Coronaviriridae: Sarbecovirus) isolate 2019-nCoV/USA-WA1-A12/2020 was obtained 254 from the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA). A 255 master virus stock (designated IRF_0394) was grown under high (biosafety level 3) 256 containment conditions at the IRF-Frederick by inoculating grivet (Chlorocebus 257 aethiops) Vero cells obtained from the American Type Culture Collection (ATCC; 258 Manassas, VA, USA; #CCL-81) maintained in Dulbecco's Modified Eagle Medium with 259 L-glutamine (DMEM, Lonza, Walkersville, MD, USA) supplemented with 2% heat-260 inactivated fetal bovine serum (FBS; SAFC Biosciences, Lenexa, KS, USA) at 37\u00b0C in a 261 humidified 5% CO2 atmosphere, harvested after 72 h, and quantified by plaque assay in 262 Vero E6 cells (ATCC #CRL-1586) using a 2.5% Avicel overlay with a 0.2% crystal 263 violet stain at 48 h following a previously published protocol (47). The genomic sequence 264 of the IRF_394 master stock was determined experimentally by two independent 265 amplification approaches: nonspecific DNA amplification (sequence-independent single 266 primer amplification [SISPA]) as described previously (48) and the ARTIC protocol (49), 267 which was designed to amplify overlapping regions of the SARS-CoV-2 reference 268 genome (MN908947.3). Primer information and genomic alignment position are 269 available at https://github.com/artic-network/artic-270 ncov2019/tree/master/primer_schemes/nCoV-2019/V1. PCR products were purified with 271 the MinElute PCR Purification Kit (QIAgen, Valencia, CA, USA). Agilent, Santa Clara, CA, USA). After quantification by qPCR with the KAPA SYBR 276 FAST qPCR Kit (Roche, Pleasanton, CA, USA), libraries were diluted to 2 nM, and 277 sequenced on a MiSeq (Illumina, San Diego, CA, USA). The genomic sequence of 278 IRF_394 was found to be identical to the type sequence of SARS-CoV--eating (aka cynomolgus) macaques (Macaca fascicularis Raffles, 1821) of both 284 sexes, 4-4.5 years old and weighing 3.17-4.62 kg (Supplementary Table 1), were 285 obtained from Cambodia via Envigo Captive (Hayward, CA, USA) and housed at the US 286 National Institutes of Health Animal Center (NIHAC; Dickerson, MD, USA) for 3 287 months. All female macaques were on depot medroxyprogesterone acetate (administered 288 intramuscularly, 150 mg/ml) while at NIHAC for several months. The last dose 289 administered was administered approximately one month prior to study start. The 290 macaques were subsequently moved into the maximum (biosafety level 4 [BSL-4]) 291 containment laboratory at the IRF-Frederick, a facility accredited by the Association for 292 Assessment and Accreditation of Laboratory Animal Care International (AAALAC). 293 Prior to facility entry, all macaques were serologically screened for herpes B virus, 294 simian immunodeficiency virus (SIV), simian retrovirus, and simian T-lymphotropic 295 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 14 virus (STLV) infection; all macaques tested negative. Macaques also tested negative 296 multiple times for Mycobacterium tuberculosis infection. Once in containment, the 297 macaques passed physical exams and routine bloodwork and were confirmed appropriate 298 for study assignment by IRF-Frederick veterinarians. Experimental procedures for this 299 study (protocol \"SARS-CoV-2-NHP-064E-1\") were approved by the National Institute of 300 Allergy and Infectious Diseases (NIAID), Division of Clinical Research (DCR), Animal 301 Care and Use Committee (ACUC), and were in compliance with the Animal Welfare Act 302 regulations, Public Health Service policy, and the Guide for the Care and Use of 303 Laboratory Animals 8 th Ed. recommendations. The macaques were singly housed during 304 the 2-week acclimatization to the maximum containment laboratory and the course of the 305 study, and were provided with appropriate enrichment including, but not limited to, 306 polished steel mirrors, durable toys, and food enrichment. Macaques were anesthetized in 307 accordance with maximum containment standard operating procedures prior to all 308 macaque manipulations, including virus exposure, sample collection, and medical 309imaging. Macaques were observed following anesthesia to ensure complete recovery. All 310 work with NHPs was performed in accordance with the recommendations of",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "examined physically, including blood draws, and conjunctival (left and right), 326 nasopharyngeal, oropharyngeal, and rectal swab collection. Stool and urine were also 327 collected on each day swabs were collected. All swabs were collected in 1-ml universal 328 virus transport (UVT) media (BD Biosciences, San Jose, CA, USA). 329 330 Macaque scoring 331 Cage-side assessment scoring criteria (Supplementary Table 4) were modified from 332 Chertow et al. (2016) to include clinical signs relevant to COVID-19 and respiratory rates 333 of crab-eating macaques (9, 50, 51). In addition to cage-side observations, physical exam 334 scoring criteria were implemented to assess clinical conditions on days when macaques 335 were anesthetized (Supplementary",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Following sample collection and intubation, macaques were moved to chest computed 359 tomography (CT) or whole-body positron emission tomography combined with CT 360 (PET/CT) imaging. For imaging procedures, each macaque was anesthetized 361 intramuscularly with 15 mg/kg ketamine following 0.06 mg/kg glycopyrrolate 362 intramuscularly. Anesthesia was maintained using a constant rate intravenous infusion of 363 propofol at 0.3 mg/kg/min (except on D-11 when propofol at 0.2 mg/kg/min was used). 364 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 17 Macaques were placed on the scanner's bed in a supine, head-out/feet-in position and 365 connected to a ventilator to facilitate breath holds, and vital signs were monitored 366 throughout the imaging process. 367 High resolution chest CT 368 Chest CT scans were performed using the 16-slice CT component of a Gemini TF 16 369 PET/CT (Philips Healthcare, Cleveland, OH, USA) or a Precedence SPECT/CT scanner 370 (Philips Healthcare). Chest CT images were acquired in helical scan mode with the 371 following parameter settings: ultra-high resolution, 140 kVp, 300 mAs/slice, 1 mm 372 thickness, 0.5 mm increment, 0.688 mm pitch, collimation 16x0.75, and 0.75 s rotation. 373 CT image reconstruction used a 512x512 matrix size for a 250-mm transverse field-of-374 view (FOV), leading to a pixel size of 0.488 mm. Two CT images were produced: one 375 with the standard \"B\" filter and one with the bone-enhanced \"D\" filter. No contrast agent 376 was administered. Each macaque underwent a 15-20-s breath-hold during acquisition. 377The pressure for the breath-hold was maintained at 150 mmH2O. 378Whole-body PET/CT 379Whole-body PET/CT scans were performed using a Gemini TF 16 TF PET/CT scanner. 380Radiotracer (2-deoxy-2-[ 18 F]-fluoro-D-glucose; FDG) was injected intravenously (0.5 381 mCi/kg FDG, up to 4.0 mCi/scan) and the time of injection was recorded. After high-382 resolution chest CT imaging with breath-hold session (\u22485 min), whole-body CT images 383 were acquired (\u22485 min) in helical scan mode with the following parameter settings: high 384 resolution, 140 kVp, 250 mAs/slice, 3 mm thickness, 1.5 mm increment, 0.688 mm pitch, 385 collimation 16x0.75, and 0.5 s rotation. Two CT images were reconstructed from the raw 386data. An initial CT image was reconstructed into a 600-mm diameter field-of-view 387 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 18(FOV), resulting in a pixel size of 1.17 mm and a slice spacing of 1.5 mm. This CT image 388 was used to create an attenuation map needed to correct the PET images for photon 389 attenuation. Raw CT data were reconstructed a second time into diagnostic quality CT 390 images by reducing the FOV size to 250 mm, resulting in a pixel size of 0.488 mm with 1 391 mm slice thickness. One CT image was produced with the standard (\"B\") filter. No 392 contrast agent was administered, and the macaques breathed freely during the scan. 393Following whole-body CT scanning, whole-body PET scans covering the macaques' 394 bodies from the top of the head to the middle of the thighs was performed after a 60-min 395 delay. Depending on the size of the NHP, 6 or 7 bed positions (with 50% overlap) were 396 needed for this scan range. Dwell time per bed position was 3 min, resulting in a total 397 duration of 18 or 21 min/scan. PET data were reconstructed into a set of either 300-or 398 342-image slices with 128x128 2-mm-cubic voxels. To ensure quantitative accuracy, all 399 reconstructed PET images were corrected during scans for radioactive decay, uniformity, 400 random coincidences, and attenuation and scattering of PET radiation in situ. Lastly, 401 whole-body CT imaging with iopamidol (600 mg iodine/kg) intravenous contrast material 402 were acquired at D-11 and the terminal D30 scans. Each macaque underwent a 30-50-s 403 breath-hold during acquisition. The pressure for the breath-hold was maintained as 150 404 mmH2O. After completion of imaging, macaques were returned to the clinical team et al. 19An adapted semi-quantitative scoring system based on a previously published method 410 (52) was used to quantitatively estimate the pulmonary involvement of lung 411 abnormalities on the extent of parenchymal lung disease in each lung lobe. The sums of 412 the lobar scores were used to generate total lung summary scores. CT scores ranged from 413 0-5 for each lobe (right upper, right middle, right lower, right accessory, left upper, left 414 middle, and left lower). Lobes were scored as: 0 = no disease involvement, 1 \u22645%, \u226575%, with a maximum total lung score of 35. Score 416 increments of 0.5 were used to indicate improvement (or worsening) in radiodensity 417 when changes in volume were insufficient to change score category. Additional data 418 points included cohort (macaques M1-3 and V1-3), scan date and study day, and number 419 of \"lesions\". Types of infiltrates (GGOs, paving, consolidation, and organizing 420 pneumonia) per lobe were given individual 0-5 scores, and the overall predominant type 421 of infiltrate per each lobe and each subject scan were recorded. The summary scores per 422 each lobe and whole lung were used as markers of disease progression. Image analysis 423 was performed by a board-certified radiologist and a research fellow using MIM software 424 version 6.9 (Cleveland, OH, USA). 425To quantify CT data, the lung field was segmented using a region-growing426 implementation (MIM software). Entire lung volumes (LV) were measured at each time 427 point (n: at time point n; b: at baseline). A histogram analysis was performed on the voxel 428 intensities (radiodensity in Hounsfield units [HU]) within the segmented lung. Percent 429 change in the volume of hyperdense lung tissue was determined as described previously 430 (53). Briefly a threshold value was determined for each subject, based on a 5% cutoff in 431 the upper tail of the histogram of lung tissue from the baseline CT scan. Due to an 432 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 20 inability to keep the lungs of the virus group macaques inflated to abnormalities (e.g., GGOs, consolidation) appear during the disease 436 process, a larger volume of tissue will have higher HU values and PCLH as percent 437 change in lung hyperdense volume (HV) from baseline can be expressed as [(HVn-438 HVb)/HVb]*100. Then PCLH/LV can be expressed as [Vn/LVn]*100. Change in average 439 lung radiodensity (LD) in the entire lung volume can be [LDn-LDb]. Change in average 440 hyperdensity in hyperdense volume can be expressed as [HDn-HDb]. Then, PCLH as 441 percent change in lung hyperdense volume, PCLH as percent of lung volume 442 (PCLH/LV), change in the average radiodensity in the entire lung and change in the 443 averaged hyperdensity in the hyperdense volume were graphed with disease progress. To 444 visualize CT abnormalities in three dimensions (3D), a volume rendering technique was 445 used to create videos. In brief, the lungs and airways were extracted form chest CT 446 images using MIM software. A region growing algorithm was used to segment different 447 classes including normal lung tissue, vessels, airways, and \"lesions\" with multiple seeds 448 at specific locations to achieve realistic segmentations. 3D volume renderings of the 449 segmentations were generated and animated rotations exhibiting the location and extent 450 of the abnormalities were produced using 3D Slicer 4 software version 4.10.2 (55). 451 452 Whole-body PET/CT evaluation 453 Analysis of imaging data was performed using MIM software. Whole-body CT and PET 454 scans for a given scanning session were co-registered. Regions of interest (ROIs) were 455 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 21 placed manually on the PET scans, and location determined on the co-registered CT 456 scans. These regions included specific lung abnormalities when present, left and right 457 lung when no specific abnormalities were present, mediastinal and hilar lymph nodes, 458 and spleen. Once ROIs were placed, mean FDG maximum standardized uptake values 459 (SUVmax) were measured from corrected PET images and averaged SUVmax values were 460 graphed longitudinally. 461 The quantitative analysis was correlated with a qualitative evaluation of CT and 462 PET/CT lung pathology over time, performed by a board-certified radiologist. 463 464 RT-qPCR 465 RT-qPCR analysis was performed to determine presence of SARS-CoV-2 RNAs in 466 collected specimens. Samples were frozen at -80\u00b0C in TRIzol LS (Thermo Fisher 467 Scientific, Wilmington, DE, USA) and thawed on ice. 100 \u03bcl of sample were added to 468 5PRIME Phase Lock tubes (Quantabio, Beverly, MA, USA) followed by addition of 20 469 \u03bcl of chloroform/tube (Sigma-Aldrich, St. Louis, MO, USA) and inversion by hand 10 470 times. Phase Lock tubes with sample and chloroform were centrifuged at 10,000 x g for 1 471 min at 4\u00b0C. Following centrifugation, aqueous phases were removed (\u224855 \u03bcl/tube) and 472 deposited into clean 1.5-ml Eppendorf tubes. 70% ethanol was subsequently added to 473 each tube at a 1:1 ratio (55 \u03bcl ethanol), inverted 10 times by hand, and briefly 474 centrifuged. The ethanol/aqueous solution containing extracted RNA was used as input 475 for purification and isolation using the PureLink RNA Mini Kit (Thermo Fisher 476 Scientific) following the manufacturer's instructions. RNA was eluted in 30 \u03bcl of water. 477 RT-qPCR was performed using the SuperScript III Platinum One-Step qRT-PCR Kit 478 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 22 (Thermo Fisher Scientific) following the manufacturer's instructions with the following 479 changes: reagent volumes were halved, resulting in 25-\u03bcl final reaction volumes. The N1 480 assay supplied with the 2019-nCoV CDC qPCR Probe Assay (Integrated DNA 481 Technologies [IDT], Coralville, IA, USA) was used (1 \u03bcl/reaction) in lieu of individual 482 primers and probes. 2 \u03bcl of extracted RNA or 2019-nCoV_N_Positive_Control (IDT) 483 were used in each reaction. Samples and controls were run in technical triplicates on a 484 CFX96 Touch Real-Time PCR Detection System (Biorad, Hercules, CA, USA) following 485 the manufacturer's recommendations; a 50\u00b0C, 15-min reverse-transcriptase step was used 486 for first strand cDNA synthesis followed by 95\u00b0C, 2-min to inactivate the reverse 487 transcriptase, followed by 45 cycles of 95\u00b0C, 15 s, 60\u00b0C, were collected in Greiner Bio-One VACUETTE Z Serum Sep Clot 491 Activator Tubes and frozen at -80\u00b0C. Before removal from the maximum containment 492 laboratory, virus in samples was inactivated using a cobalt irradiation source with a target 493 dose of 50 kGy (JLS 484R-2 Cobalt-60 [ 60 Co] Irradiator, JLShephard & Associates) 494 following standard inactivation protocols. Serum samples were subsequently heat-495 inactivated at 56\u00b0C for 30 min prior to antibody screening. To determine IgG titers, 496 Immulon 2HB 96-well plates (Thermo Fisher Scientific) were coated with recombinantly 497 expressed SARS-CoV-2 spike S1 subunit (Sino Biological, Wayne, PA, USA) at 0.1 498 \u03bcg/well in 50 \u03bcl/well overnight at 4\u00b0C. Plates were washed three times with phosphate-499 buffered saline (PBS) + 0.1% Tween20 (PBS_T; Sigma-Aldrich) and blocked with 500 ELISA diluent (5% nonfat milk [LabScientific, Danvers, MA, USA] in PBS-T) for 1 . After blocking, plates were washed three times with PBS-T and 100 503 \u03bcl/well of diluted sample were transferred to the plate. Samples were incubated for 1 h at 504 37\u00b0C. Plates were then washed three times with PBS-T, and 100 \u03bcl of goat anti-human 505 IgG Fc specific (Jackson ImmunoResearch, West Grove, PA, USA) secondary antibody 506 conjugated to horseradish peroxidase (HRP; diluted 1:20,000 in ELISA diluent) were 507 added to each well. Samples were incubated for 1 h at 37\u00b0C and finally washed five times 508 with PBS-T. Plates were developed by adding 100 \u03bcl of TMB substrate (Thermo Fisher 509 Scientific) at room temperature for 10 min in the dark. Development was stopped by the 510 addition of 100 \u03bcl of Stop Solution (Thermo Fisher Scientific). Plates were read at 450 511 nm with a correction wavelength of 650 nm using a Spectramax Plus 384 (Molecular 512 Devices, San Jose, CA, USA) within 30 min of stopping the reaction. Reciprocal 513 endpoint titers were determined in GraphPad software version 8.4.2 (Prism, La Jolla, CA, 514 USA), using a sigmoidal 4 parameter-logistic fit curve. Endpoint titers were calculated at 515 the point when the curve crossed the ELISA cutoff value. For the S1 subunit IgG ELISA, 516 the cutoff value was determined to be an optical density (OD) of 0.19077, which was 517 determined from control sera collected from twenty-five NHPs sampled prior to the 518 known emergence of SARS-CoV-2. Data are presented as the mean and standard 519 deviation of two independent ELISA runs. 520 521 Fluorescence neutralization assay 522All assays were run with irradiated and heat-inactivated sera. Irradiation and heat-523 inactivation were performed as described above. Vero E6 cells were seeded at 3x10 4 ml cluster tubes (Corning Inc, Corning, NY, USA). Then, stock SARS-CoV-2 virus 528 was diluted in serum free media and was added to the sera in each cluster tube at a 529 multiplicity of infection (MOI) of 0.5 using a liquidator, doubling the total volume in 530 each well and further diluting sera 1:2. Thus, the final starting dilution was 1:40. The 531 sera/virus mixtures were then mixed by pipetting up and down with the liquidator. 532Cluster tubes were next incubated for 1 h at 37\u00b0C/5% CO2.Following incubation, 100 533 \u00b5l/well of each virus/serum mixture were transferred to the Operetta plates from the 534 cluster tubes to yield final volumes of 200 \u00b5/well (100 \u00b5l cell seeding media plus 100 \u00b5l 535 virus/serum mixture). Each set of cluster tubes provided enough material for each sample 536 to be run in duplicate in 2 plates, yielding a total of 4 replicates per sample. The 537 virus/serum mixtures were incubated on plates for 24 h at 37\u00b0C/5% CO2. Subsequently, 538 plates were fixed with 20% neutral buffered formalin (Thermo Fisher Scientific) for 24 h 539 at 4\u00b0C. Next, plates were washed with PBS (Thermo Fisher Scientific) and then blocked 540 with 3% bovine serum albumin (BSA) in 1X PBS for 30 min on a rocker. Staining 541 followed, first with the primary antibody and then the secondary antibody. The primary 542 antibody was SARS-CoV-2 Nucleoprotein/NP Antibody, Rabbit mAb (Sino Biological, 543 Chesterbrook, PA, USA) prepared at 1:8,000 in blocking buffer at room temperature. 544 Plates were incubated with primary antibody for 60 min on a rocker. The secondary 545 antibody was goat \u03b1-rabbit IgG (H+L), Alexa Fluor 594 Conjugate (Thermo Fisher 546 Scientific) prepared at 1:2,500 in 1X PBS. Plates were incubated with secondary antibody 547 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 25 at room temperature for 30 min on a rocker and in the dark. Between the blocking, 548 primary, and secondary steps, plates were washed three times with 1X PBS. USA) with at least 4 fields of view of >1,000 cells each. Data were analyzed using 551 Harmony software (PerkinElmer). Half-maximal neutralization titers (NT50) were 552 calculated by averaging the fluorescence intensity in virus control wells and dividing by 553 two. The fluorescence intensity of a sample at each dilution was compared to the NT50 554 values, and the lowest dilution that is equal to or less than the NT50 value was recorded. -Immunology Multiplex Assay (Millipore, Burlington, MA, USA; #PCYTMG-559 40K-PX23) was performed on collected plasma samples following the manufacturer's 560 instructions. All reagents were warmed to room temperature prior to addition to assay 561 wells. Quality controls and standards were reconstituted with 250 \u00b5l of deionized water 562 and allowed to sit for 10 min prior to use. A four-fold seven-point standard curve was 563 generated by diluting the concentrated stock with assay buffer for each point. Assay 564 buffer alone served as the blank. The plate was first washed with 200 \u00b5l of assay buffer 565 and incubated on an orbital shaker at 800 rpm at room temperature for 10 min. Assay 566 buffer was decanted, and plates were inverted on absorbent paper to remove any excess 567 buffer. 25 \u00b5l of serum matrix were added to background, control, and standard wells. 25 568 \u00b5l of assay buffer was added to sample wells. 25 \u00b5l of samples/standards/controls were 569 added to the appropriate wells. Beads were resuspended by vortexing and 25 \u00b5l were of 570 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 26vortexed beads were added to each well. Each plate was sealed and incubated overnight 571 at 4\u00baC on an orbital shaker at 500 rpm. The next day, plates were washed twice using a 572 hand-held magnetic plate holder with 200 \u00b5l of wash buffer per well and decanted as 573 previously described. Plates were then incubated on an orbital shaker at 500 rpm at room 574 temperature for 1 h with 25 \u00b5l of detection antibody. After incubation, 25 \u00b5l of kit-575 provided streptavidin-phycoerythrin were added directly to each well and incubated at 576 room temperature on an orbital shaker at 500 rpm for 30 min. Plates were washed twice 577 and 150 \u00b5l of sheath fluid was added to each well. Plates were read on a Flexmap 3D 578 reader (Luminex, Chicago, IL, USA) within 24 h of completion following assay 579 instructions. The data was exported to Bio-Results Generator version 3.the curve (AUC) summaries were calculated using the trapezoidal rule, and 585 compared using Welch's t-tests, using R version 3.this study were made available publicly as soon as they became available at 589 https://openresearch.labkey.com/project/Coven/COVID-001/begin.view to inform the 590 ongoing COVID-19 outbreak response without delay following practices we initiated for 591NHP studies of Zika virus pathogenesis in 2016 (56et al. 28 and J.S., who were supported by the Clinical Monitoring Research Program Directorate, 617 Frederick National Lab for Cancer Research, sponsored by NCI. The views and 618 conclusions contained in this document are those of the authors and should not be 619 interpreted as necessarily representing the official policies, either expressed or implied, of 620 the US Department of Health and Human Services or of the institutions and companies 621 affiliated with the authors. The study protocol was reviewed and approved by the 622 NIH/NIAID/DCR/Integrated Research Facility at Fort Detrick, Frederick, MD, USA 623 Animal Care and Use Committee in compliance with all applicable federal regulations 624 governing the protection of animals and research. 625 626 Author contributions. C.L.F., I.C., J.H.L., T.K.C., J.R.K., M.C.St.C., M.G.L., R.F.J., 627 K.M.B., M.R., C.S., T.C.F., D.H.O'C., and J.H.K. contributed to the study conception 628 and design. C.L.F., J.H.L., R.B., T.K.C., J.L., K.S., P.J.S., G.K., C.B., P.A.L., R.A., B.B., 629 N.D.P., J.R.K., T.B., M.C.St.C. contributed to study performance, and sample and data 630 collection. C.L.F., I.C., J.H.L., R.B., T.K.C., J.L., J.S., P.S., C.B., N.A., M.C., T.C.F., 631 P.A.L., B.B., N.D.P., J.R.K., J.R.K., M.C.M., I.M.F., G.P., J.W., T.C.F, D.H.O'C., and 632 J.H.K. contributed to data analyses, interpretation, and writing. All authors read and 633 approved the final manuscript. 634 635 Competing interest declaration. The authors declare no competing interests. 636 Legends",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "et al. Study overview. Three crab-eating macaques (Macaca fascicularis) were 639 exposed to \u22483.65x10 6 pfu SARS-CoV-2 each by direct bilateral primary post-carinal 640 intrabronchial instillation and sampled as outlined. A second group of three crab-eating 641 macaques was mock-exposed and sampled in the same manner one day prior to the virus-642 exposed group (exception: a second baseline CT image was recorded for each group on Detection of SARS-CoV-2 RNA and specific immune responses in SARS-646CoV-2-inoculated and mock-inoculated macaques. a) RT-qPCR targeting the SARS-647CoV-2 N protein was performed from baseline through D10 in nasopharyngeal swabs for 648 macaques of both groups. b) Anti-SARS-CoV-2 S1 subunit IgG ELISA results are 649expressed as reciprocal endpoint titers over time for both mock group (M) and virus 650 group (V) macaques. c) Fluorescence neutralization assays were performed on sera from 651 all macaques on all days. NT50, half-maximal neutralization titer. 652 COVID-19-like CT abnormalities in the lungs of SARS-CoV-2 inoculated 654 macaques V1 (a-b), V2 (c-g), and V3 (h-j). Distribution of CT scan abnormalities in 655 3D images of SARS-CoV-2-inoculated macaque V1 (a), V2 (c), and V3 (h). Blue: 656 airways; gray: normal lung; red: vessels; yellow: imaging abnormalities. b) Selected 657 characteristic abnormalities in macaque V1 include peripheral, peri-bronchial ground-658 glass opacity (GGO) in the left middle lobe (green inset, top, red arrow) and peripheral 659 GGO with reticulation in the posterior right lower lobe (green inset, bottom, yellow 660 arrow). d-g) Selected characteristic abnormalities in macaque V2 include d) peri-661 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 30 bronchial consolidation in the left accessory lobe (blue inset, top, red arrow) and 662 posterior GGO with reticulation in the posterior right lung (blue inset, bottom, red arrow), 663 e) bilateral posterior GGO with reticulation (blue inset, top and bottom, red arrows), f) 664 GGO with superimposed paving (interlobular septal thickening) in right posterior lung 665 (blue inset, top) and mixed GGO with pleural-based consolidation in left posterior lung 666 (blue inset, bottom), and g) pleural-based mixed GGO and consolidation developing on 667 D6 (blue inset, blue arrow). i-j) Selected characteristic abnormalities in macaque V3 668 include i) GGO with air bronchogram in right posterior lung (orange inset, top, purple 669 arrow), alveolar consolidation with peripheral GGO and air bronchogram in left posterior 670 lung (orange inset, bottom, blue arrow), and j) expanding and more dense alveolar 671 consolidation with air bronchogram on D4 (orange inset, blue arrow). Representative 3D-672 rendered videos of a), c), and h) demonstrating whole-lung pathology are shown in 673 Videos 1-3, respectively. 674 Qualitative and quantitative computed tomography (CT) analysis of 676 macaque lungs. a) Representative axial CT images in three SARS-CoV-2-infected (V) 677 macaques for each indicated study day (D). The grey scale represents radiodensity in 678 Hounsfield units (HU). b) Percent change in volume of lung hyperdensity (PCLH) 679 measured over time in the same SARS-CoV-2 inoculated macaques shown in a). 680 Representative axial CT images and PCLH for all study days in both groups, including 681 data for mock group (M) macaques, are shown in Supplementary Figure In Radiologist-derived CT lung scores of macaque lungs. Averaged 687 radiologist-derived CT scores of the entire lungs for individual macaques (a) and 688 averaged for mock group (M) and virus group (V) macaques (b) over time. 689 Qualitative positron emission tomography (PET) and FDG uptake 691 analysis in macaque lung and regional lymph nodes. Representative coronal 2-deoxy-692 2-[ 18 F]-fluoro-D-glucose (FDG) PET/CT images for each indicated study day (D) from 693pre-inoculation baseline to 12 days after inoculation. SUVmax, maximum standardized 694 FDG uptake value. Selected areas of increased FDG uptake are indicated in lung 695 parenchyma (yellow arrows, blue arrows) and regional lymph nodes (pink arrows). All 696 study days and data for mock group (M) macaques are shown in SupplementaryFigure 697",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Selected PET/CT images (axial, sagittal, and coronal views) including detailed 698 radiological descriptions are shown in Supplementary Figure 5. 699 Quantitation of 2-deoxy-2-[ 18 F]-fluoro-D-glucose (FDG) uptake in lung, lymph 701 nodes, and spleen. a) SUVmax (mean FDG maximum standardized uptake values) for 3-5 702 selected lung regions of interest (ROIs) with high FDG uptake with tracking of identical 703 regions of interests at all PET/CT timepoints in each macaque and b) averaged for mock 704 group (M) and virus group (V) macaques. c) SUVmax for 2-3 selected lymph node ROIs 705 with high FDG uptake in each macaque and d) averaged for (M) and (V) group 706 SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 32 macaques. e) SUVmax for spleen FDG uptake in each macaque and f) averaged for (Quantitative analyses of volume and radiodensity of macaque lungs. a-b) 710 Percent change in volume of lung hyperdensity (PCLH) measured over time for 711 individual macaques (a) as in Figure 4b and averaged for mock group (M) and virus 712 group (V) macaques (b). c-d) PCLH standardized as percent of entire overall lung 713 volumes over time (PCLH/LV) for individual macaques (c) and averaged for M and V 714 macaques (d). e-f) Change in the average lung densities (Hounsfield units [HU]) in the 715 entire lung volumes over time for individual macaques (e) and averaged for M and V 716 macaques (f). g-h) Change in average lung hyperdensities (HU) in the lung hyperdense 717 volume over time for individual macaques (g) and averaged for M and V macaques (h). 718 719 Videos 1-3 | Qualitative computed tomography (CT) analysis of macaque lungs. 3D 720 rendering of the lungs of macaque V1 at D2 (Video 1), V2 at D4 (Video 2), and V3 at D4 721 (Video 3) after SARS-CoV-2 exposure. Blue: airways; gray: normal lung; red: represented on logarithmic scales. For graphic representation, values of \"0\" or 727 \"not detected\" (below the level of assay sensitivity) were automatically assigned a Qualitative and quantitative computed tomography (CT) 731 analysis of macaque lungs. a) Representative axial CT images in three SARS-CoV-2-732 infected (V) macaques and mock-inoculated (M) macaques for all indicated study days 733 (D). The grey scale represents radiodensity in Hounsfield units (HU). Selected CT images 734 (axial, sagittal, and coronal views) from the SARS-CoV-2 infected macaques with 735 detailed radiological descriptions are shown in Supplementary Figure 3. Colored arrows 736 in Figure 4 and this figure represent regions of interest that are further detailed in figure 737 legends for Supplementary Figure 3. b) Percent change in lung hyperdensity (PCLH) 738 measured over time in the same macaques shown in Figure 4, including also here the 739 mock-infected individual macaques and all study days. 740 Qualitative computed tomography (CT) analysis of 742 macaque lungs. 743 744 Supplementary Figure 4 | Qualitative positron emission tomography (PET) and 745 PET/CT analysis of macaque lungs. Representative coronal (left panels) of increased FDG uptake are highlighted in the lung parenchyma (yellow 749 arrows) and regional lymph nodes (pink arrows). Selected merged PET/CT images (axial, 750 sagittal, and coronal views) with detailed radiological descriptions of these areas of 751 interest are shown in Supplementary Figure 5. 752 753 Supplementary Figure 5 | Qualitative positron emission tomography (PET) and 754 PET/CT analysis of macaque lungs. 755 756 Supplementary",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "Figure 1",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "Figure 3",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "Figure 4",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Figure 5",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "Figure 6",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "Figure 7",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "Figure 8",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "SARS-CoV-2 pulmonary abnormalities in macaques Finch et al. 16 macaque V3, for which heart rate was not recorded prior to dexmedetomidine 342 Blood samples were collected in Greiner Bio-One Hematology K3EDTA Evacuated 346 Tubes (Thermo Fisher Scientific). Complete blood counts, including leukocyte 347 differentials and reticulocyte counts (CBC/Diff/Retic), were determined using the Procyte 348 DX (IDEXX Laboratories, Westbrook, ME, USA). The Catalyst One analyzer (IDEXX 349 Laboratories) was used for biochemical analyses of serum samples, which were collected 350 in Greiner Bio-One VACUETTE Z Serum Sep Clot Activator Tubes (Thermo Fisher 351 Scientific). Samples were run on both machines the day of collection shortly following 352 collection such that they were not stored prior to analysis. On D30, an equipment issue 353 with the Procyte DX required that samples from the virus-exposed group be stored at 4\u00b0C 354 for about 30 h prior to analysis. For a list of all measured parameters and their values, see 355",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Crab-eating macaque (Macaca fascicularis Raffles, 1821) 757 Supplementary Table 2 | Macaque physical condition/clinical scoring results. 760 Supplementary Table 3 | Complete blood cell count (CBC/Diff/Retic) and serum 762 Supplementary Table 4 |Macaque clinical scoring guide.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "Anti-SARS-CoV-2 S1 Subunit IgG ELISA ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}